Fig. 1 · Structure

Documents & Downloads

Dapivirine

Cat. No. A12587 CAS 244767-67-7

HIV reverse transcriptase inhibitor

Dapivirine is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI)

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
HIV reverse transcriptase 24 nM

Cellular Effect

Cell Line Activity Value Description Reference
Caco-2 IC50 0.73 μM Determination of IC50 values for inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells after 48 hours by high content imaging 10.21203/rs.3.rs-23951/v1
Caco-2 CC50 5 μM Toxicity against Caco-2 cells determined at 48 hours by intracellular ATP concentration using the CellTiter-Glo Luminescent Cell Viability Assay 10.21203/rs.3.rs-23951/v1
Macrophage CC50 > 20000 nM Cytotoxicity against human monocyte derived macrophages after 24 hrs by MTT assay [PMID: 19029331]
MRC5 IC50 > 64 μM Cytotoxicity against human MRC5 SV2 cells assessed as reduction in cell growth after 72 hrs [PMID: 25199582]
MRC5 IC50 1.25 μM Trypanocidal activity against nifurtimox-sensitive Trypanosoma cruzi Tulahuen CL2 infected in human MRC5 SV2 cells assessed as parasite growth inhibition after 168 hrs by beta-galactosidase assay [PMID: 25199582]
MT2 EC50 0.0007 μM Antiviral activity against wild type HIV1 3B infected in human MT2 cells assessed as protection against virus-induced effect by MTT assay [PMID: 23937980]
MT2 EC50 0.039 μM Antiviral activity against HIV1 3B harboring reverse transcriptase K103N/Y181C double mutant infected in human MT2 cells assessed as protection against virus-induced effect by MTT assay [PMID: 23937980]
MT2 EC50 0.039 μM Antiviral activity against HIV1 3B harboring reverse transcriptase Y181C mutant infected in human MT2 cells assessed as protection against virus-induced effect by MTT assay [PMID: 23937980]
MT2 CC50 1.9 μM Cytotoxicity against human MT2 cells after 5 days by MTT assay [PMID: 24900627]
MT4 EC50 > 20 μM Antiviral activity against TMC120-resistant HIV1 harboring RT 100I, 138G mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by MTT assay [PMID: 24805780]
MT4 EC50 > 20 μM Antiviral activity against TMC125-resistant HIV1 harboring RT 109M, 138K, 190E mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by MTT assay [PMID: 24805780]
MT4 EC50 0.001 μM Antiviral activity against zidovudine-resistant HIV1 harboring RT 67N, 70R, 215F, 219Q mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by MTT assay [PMID: 24805780]
MT4 EC50 0.002 μM Antiviral activity against MDR-resistant HIV1 harboring 41L, 74V, 106A, 215Y mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by MTT assay [PMID: 24805780]
MT4 EC50 0.003 μM Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by MTT assay [PMID: 24805780]
MT4 EC50 0.003 μM Antiviral activity against saquinavir-resistant HIV1 infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by MTT assay [PMID: 24805780]
MT4 EC50 0.03 nM Antiviral activity against wild type HIV 1 NL4-3 infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 5 days by MTT assay [PMID: 21438533]
MT4 EC50 0.04 μM Antiviral activity against N119-sensitive HIV1 harboring Y181C mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by MTT assay [PMID: 24805780]
MT4 EC50 0.05 μM Antiviral activity against A17-sensitive HIV1 harboring 103N, 181C mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by MTT assay [PMID: 24805780]

18 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 244767-67-7
Applications HIV reverse transcriptase inhibitor
Formula C20H19N5
Molecular Weight 329.4
Synonyms R 147681; TMC 120; TMC 120R147681
SMILES
CC1=CC(=C(C(=C1)C)NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 29 mg/mL (88.03 mM)
Water Insoluble
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...